EUVIMEDEUVIMED entdecken
Crossref

Far from the truth: Real‐world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification

Xinyan Yang iD, Yu Guang Tan, Rene Gatsinga, Weiren Chen, Hong Hong Huang, Jeffrey Tuan Kit Loong iD, Melvin Lee Kiang Chua, Tanujaa Rajasekaran, Ravindran Kanesvaran, Kae Jack Tay iD, Kenneth Chen, John Shyi Peng Yuen

International Journal of Urology · 2023

DOI: 10.1111/iju.15243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, 2023. Verfasst von Xinyan Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Singapore General Hospital, Singapore. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Prostatic Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Real‐world uptake of treatment intensification (TI) with novel hormonal agents (NHA) or chemotherapy as treatment of metastatic prostate cancer remains low outside of trial settings. We aim to report the prescription patterns and treatment outcomes of de novo metastatic hormone‐sensitive prostate cancer (mHSPC) in a tertiary institution.

Methods

This is a retrospective cohort study using real‐world data from a prospectively maintained prostate cancer registry. We selected patients newly diagnosed with mHSPC from January 2016 to December 2020. Clinicopathological parameters were recorded to determine their impact on prescription patterns.

Results

In total, 585 patients with metastatic prostate cancer were identified. Prescription of NHA increased from 10.5% (2016) to 50.4% (2020), but that of chemotherapy declined. Factors associated with TI were (1) baseline health status: Charlson Comorbidity Index 0–2, ECOG 0–1, age ≤ 65, (2) disease burden: PSA (>400, CHAARTED high volume disease, p = 0.004), development of systemic complications and (3) physician factor: primary physician being uro‐oncologist and medical oncologist versus general urologist. Patients with TI had a longer mean time to castration‐resistant prostate cancer (45.0 vs. 32.5 months, HR 0.567, 95% CI: 0.441–0.730, p < 0.001) and overall survival (55.3 vs. 46.8 months, HR 0.612, 95% CI, 0.447–0.837, p = 0.001).

Conclusion

This study demonstrated the trend of treatment prescription of mHSPC and factors contributing to the use of TI. TI improved mean time to CRPC and OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantProstatic NeoplasmsMaleHumansRetrospective StudiesTreatment OutcomeProstateRegistriesAndrogen Antagonists

Stichwörter der Autor:innen

chemotherapymetastatic hormone-sensitive prostate cancernovel hormonal agentsprescription patternstreatment intensification

Substanzen

Androgen Antagonists

Autor:innen und Institutionen

  • Department of Urology, Singapore General Hospital, Singapore.
  • Division of Radiation Oncology, National Cancer Centre, Singapore.
  • Division of Medical Oncology, National Cancer Centre, Singapore.

ORCID-Profile: Xinyan Yang, Jeffrey Tuan Kit Loong, Kae Jack Tay

Zitieren

APA

Yang, X., Tan, Y. G., Gatsinga, R., Chen, W., Huang, H. H., Loong, J. T. K., Chua, M. L. K., Rajasekaran, T., Kanesvaran, R., Tay, K. J., Chen, K., & Yuen, J. S. P. (2023). Far from the truth: Real‐world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification. International Journal of Urology. https://doi.org/10.1111/iju.15243

Vancouver

Yang X, Tan YG, Gatsinga R, Chen W, Huang HH, Loong JTK, et al. Far from the truth: Real‐world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification. International Journal of Urology. 2023. doi:10.1111/iju.15243

BibTeX
@article{Yang2023,
  author = {Yang, Xinyan and Tan, Yu Guang and Gatsinga, Rene and Chen, Weiren and Huang, Hong Hong and Loong, Jeffrey Tuan Kit and Chua, Melvin Lee Kiang and Rajasekaran, Tanujaa and Kanesvaran, Ravindran and Tay, Kae Jack and Chen, Kenneth and Yuen, John Shyi Peng},
  title = {Far from the truth: Real‐world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification},
  journal = {International Journal of Urology},
  year = {2023},
  doi = {10.1111/iju.15243}
}
Kostenlos starten →